M. Kulyk & Associates, LLC Novo Nordisk A S Transaction History
M. Kulyk & Associates, LLC
- $443 Million
- Q2 2025
A detailed history of M. Kulyk & Associates, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 77,322 shares of NVO stock, worth $4.54 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
77,322
Previous 65,897
17.34%
Holding current value
$4.54 Million
Previous $4.58 Million
16.63%
% of portfolio
1.2%
Previous 1.08%
Shares
7 transactions
Others Institutions Holding NVO
# of Institutions
1,749Shares Held
322MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.11 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$865 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$839 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$739 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$683 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $133B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...